Premier Energies (PREMIERENE) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
19 Nov, 2025Executive summary
Premier Energies, a leading Indian solar cell and module manufacturer with 29 years of legacy, expanded capacity to 2 GW for cells and 4.13 GW for modules as of September 2024.
Recognized as the largest Indian solar cell exporter to the US, with modules rated as top performers in PVEL's 2023 and 2024 reliability scorecards.
Board approved unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2024, and resolved to enter aluminium frame manufacturing for solar modules.
Statutory auditors issued unmodified review conclusions for both standalone and consolidated results.
Financial highlights
Consolidated revenue for Q2 FY25 was ₹15,535.92 million, up from ₹7,018.06 million in Q2 FY24 but down from ₹16,687.90 million in Q1 FY25.
Consolidated net profit for Q2 FY25 was ₹2,059.46 million, compared to ₹1,981.60 million in Q1 FY25 and ₹528.58 million in Q2 FY24.
Q2 FY25 revenue reached ₹1,553.59 Cr, up 121.4% year-over-year but down 6.9% sequentially from Q1 FY25.
EBITDA for Q2 FY25 stood at ₹406.95 Cr, up 280.2% year-over-year and 9.9% sequentially; EBITDA margin improved to 26.19%.
Export revenue in Q2 FY25 was ₹1,484.16 Cr, with domestic revenue at ₹136.11 Cr; module sales dominated revenue mix.
Outlook and guidance
Expansion plans include a 1 GW TopCon cell line by Q4 FY25, a 4 GW integrated TOPCon facility by FY28, and 1.2 GW cell manufacturing in the US by FY26.
IPO proceeds will fund a 4 GW Solar PV TOPCon Cell and Module facility in Hyderabad, supporting future growth.
Board approved entry into aluminium frame manufacturing for solar modules, expanding product portfolio.
2 GW wafer manufacturing and 36,000 T aluminum frame manufacturing targeted for FY26.
Latest events from Premier Energies
- Record revenue, profit, and expansions drive growth, supported by strong demand and efficiency.PREMIERENE
Q3 25/2623 Jan 2026 - Q3 FY25 revenue up 145% YoY, PAT up 490%, cell utilization at 96%, expansion ongoing.PREMIERENE
Q3 24/259 Jan 2026 - FY 2025 saw record revenue, profit growth, and major expansion with strong policy support.PREMIERENE
Q4 24/2518 Nov 2025 - Record Q1 FY26 revenue and profit, major capacity expansion, and interim dividend declared.PREMIERENE
Q1 25/2629 Oct 2025 - Record revenue, profit, and capacity expansion drive growth amid strong policy support.PREMIERENE
Q2 25/2629 Oct 2025